CAPTRUST FINANCIAL ADVISORS
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1512024
RALEIGH, NC
Position in REGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$22,736,762
-$7,011,423 QoQ
Shares Held
36,464
-5.3% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#200
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 61%
Shared 0%
None 39%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CAPTRUST FINANCIAL ADVISORS holds $167,363,866 across 124 Biotechnology names. REGN ranks #1 (13.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
36,464 | $22,736,762 | |
| 2 | RPRX |
Royalty Pharma plc
|
337,298 | $18,912,298 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
35,471 | $17,619,509 | |
| 4 | EXEL |
Exelixis, Inc.
|
303,042 | $16,488,515 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
34,607 | $10,938,926 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
125,946 | $9,857,793 | |
| 7 | CELC |
Celcuity Inc.
|
71,445 | $7,474,575 | |
| 8 | INCY |
Incyte Corp
|
50,301 | $5,702,121 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,736,762 | 36,464 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $29,748,185 | 38,502 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $16,347,434 | 21,179 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $8,106,246 | 14,417 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $5,629,575 | 10,723 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $9,061,878 | 14,288 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $7,063,464 | 9,916 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $9,597,821 | 9,130 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $9,284,799 | 8,834 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $8,565,198 | 8,899 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $11,017,269 | 12,544 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $10,254,904 | 12,461 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $8,675,651 | 12,074 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $10,190,351 | 12,402 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $9,143,442 | 12,673 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $7,900,650 | 11,469 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $6,293,761 | 10,647 | Shares | Sole | 2022-08-23 | |
| 2022-03-31 | $6,605,656 | 9,458 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $6,254,574 | 9,904 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,951,220 | 6,529 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $1,057,316 | 1,893 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $893,761 | 1,889 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $898,101 | 1,859 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,186,733 | 2,120 | Shares | Sole | 2020-11-17 | |
| 2020-06-30 | $1,052,721 | 1,688 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $730,481 | 1,496 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||